IPOs and Secondaries
IPOs and Secondaries Articles
Cibus Ltd. filed an S-1 form with the U.S. Securities and Exchange Commission (SEC) regarding its initial public offering. No pricing details were mentioned in the filing but the offering is valued...
Published:
Last Updated:
Virgin Trains registered an S-1 form with the U.S. Securities and Exchange Commission (SEC) in regards to its initial public offering.
Published:
Last Updated:
Beyond Meat filed an S-1 form with the U.S. Securities and Exchange Commission (SEC) regarding its initial public offering (IPO). No pricing details were given in the filing, although the offering is...
Published:
Last Updated:
Biopharmaceutical company Synthorx has filed with the SEC regarding its initial public offering.
Published:
Last Updated:
Snap is being investigated, Toys "R" Us has a new Chapter 11 payment plan, Starbucks will cut some corporate workers, and other important business headlines.
Published:
Last Updated:
Newly appointed CEO Larry Culp is proving that he wants to act fast in selling off GE assets and scaling the company and its debt leverage lower by unloading part of its Baker Hughes stake sooner...
Published:
Last Updated:
Biotech company Moderna has filed with the SEC regarding its initial public offering.
Published:
Last Updated:
OPEC may cut output, SAP makes a major acquisition, "The Grinch" is number one at the box office, and other important business headlines.
Published:
Last Updated:
Manufactured homes seller Legacy Housing has filed with the SEC regarding its initial public offering.
Published:
Last Updated:
The quiet period for analysts who work for the Anaplan underwriting syndicate firms has been lifted, and some of the analysts see pretty solid upside ahead. All in all, it's a mixed group of analyst...
Published:
Last Updated:
Medical technology company Vapotherm intends to price 4 million shares for and initial public offering valued up to more than $73 million.
Published:
Last Updated:
After a busy post-Labor Day period, the IPO market took a breather last week with just three of five potential offerings actually making it.
Published:
Last Updated:
There are eight IPOs on the calendar for the coming week of which five are biotech firms. If all are successful, they will have raised a total of $500 million in fresh capital.
Published:
Last Updated:
Biopharmaceutical company Orchard RX is offering more than 13 million shares in an initial public offering valued up to more than $245 million.
Published:
Last Updated:
Proteostasis Therapeutics shares pulled back on Tuesday after the company announced that it would be conducting a secondary offering.
Published:
Last Updated: